DE2601646A1 - Neue prostaglandin-analoga - Google Patents

Neue prostaglandin-analoga

Info

Publication number
DE2601646A1
DE2601646A1 DE19762601646 DE2601646A DE2601646A1 DE 2601646 A1 DE2601646 A1 DE 2601646A1 DE 19762601646 DE19762601646 DE 19762601646 DE 2601646 A DE2601646 A DE 2601646A DE 2601646 A1 DE2601646 A1 DE 2601646A1
Authority
DE
Germany
Prior art keywords
methyl
hydrogen
butyl
radical
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19762601646
Other languages
German (de)
English (en)
Other versions
DE2601646C2 (enrdf_load_stackoverflow
Inventor
Romeo Ciabatti
Umberto Guzzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit SpA filed Critical Lepetit SpA
Publication of DE2601646A1 publication Critical patent/DE2601646A1/de
Application granted granted Critical
Publication of DE2601646C2 publication Critical patent/DE2601646C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19762601646 1975-01-24 1976-01-17 Neue prostaglandin-analoga Granted DE2601646A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3248/75A GB1538871A (en) 1975-01-24 1975-01-24 Prostaglandins

Publications (2)

Publication Number Publication Date
DE2601646A1 true DE2601646A1 (de) 1976-07-29
DE2601646C2 DE2601646C2 (enrdf_load_stackoverflow) 1987-07-02

Family

ID=9754749

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762601646 Granted DE2601646A1 (de) 1975-01-24 1976-01-17 Neue prostaglandin-analoga

Country Status (28)

Country Link
JP (1) JPS6024098B2 (enrdf_load_stackoverflow)
AR (1) AR212328A1 (enrdf_load_stackoverflow)
AT (1) AT351186B (enrdf_load_stackoverflow)
BE (1) BE837865A (enrdf_load_stackoverflow)
CA (1) CA1076569A (enrdf_load_stackoverflow)
CH (1) CH609682A5 (enrdf_load_stackoverflow)
CS (1) CS187333B2 (enrdf_load_stackoverflow)
DD (1) DD122517A5 (enrdf_load_stackoverflow)
DE (1) DE2601646A1 (enrdf_load_stackoverflow)
DK (1) DK27376A (enrdf_load_stackoverflow)
FI (1) FI64578C (enrdf_load_stackoverflow)
FR (1) FR2298322A1 (enrdf_load_stackoverflow)
GB (1) GB1538871A (enrdf_load_stackoverflow)
GR (1) GR58537B (enrdf_load_stackoverflow)
HU (1) HU174185B (enrdf_load_stackoverflow)
IE (1) IE43821B1 (enrdf_load_stackoverflow)
IL (1) IL48870A (enrdf_load_stackoverflow)
LU (1) LU74240A1 (enrdf_load_stackoverflow)
NL (1) NL185203C (enrdf_load_stackoverflow)
NO (1) NO147714C (enrdf_load_stackoverflow)
NZ (1) NZ179816A (enrdf_load_stackoverflow)
PH (1) PH14040A (enrdf_load_stackoverflow)
PT (1) PT64737B (enrdf_load_stackoverflow)
RO (1) RO71901A (enrdf_load_stackoverflow)
SE (1) SE446726B (enrdf_load_stackoverflow)
SU (1) SU607550A3 (enrdf_load_stackoverflow)
YU (1) YU40805B (enrdf_load_stackoverflow)
ZA (1) ZA7681B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194055A (en) * 1976-03-03 1980-03-18 American Cyanamid Company 15,16-dioxy prostenoic acids and esters

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064350A (en) * 1976-11-22 1977-12-20 G. D. Searle & Co. 15,16-Dihydroxyprostaglandins
IT1162731B (it) * 1979-04-10 1987-04-01 Lepetit Spa 16-metil-16-metossi-5,6-diidro-prosta-glandine della serie e1 ad attivita'antisecretoria
JPS56162014A (en) * 1980-05-16 1981-12-12 Nippon Denso Co Ltd Measuring device for flow rate of gas

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2223366A1 (de) * 1971-05-11 1973-02-08 Ici Ltd Verfahren zur herstellung einer ptfe-schicht auf einer oberflaeche
DE2322673A1 (de) * 1972-05-10 1973-11-22 Upjohn Co Neue verbindungen vom prostaglandintyp und verfahren zu ihrer herstellung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2223366A1 (de) * 1971-05-11 1973-02-08 Ici Ltd Verfahren zur herstellung einer ptfe-schicht auf einer oberflaeche
DE2322673A1 (de) * 1972-05-10 1973-11-22 Upjohn Co Neue verbindungen vom prostaglandintyp und verfahren zu ihrer herstellung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194055A (en) * 1976-03-03 1980-03-18 American Cyanamid Company 15,16-dioxy prostenoic acids and esters

Also Published As

Publication number Publication date
NL7600696A (nl) 1976-07-27
YU11176A (en) 1982-10-31
PT64737A (fr) 1976-02-01
NZ179816A (en) 1978-04-03
LU74240A1 (enrdf_load_stackoverflow) 1976-07-23
JPS6024098B2 (ja) 1985-06-11
RO71901A (ro) 1982-02-26
PT64737B (fr) 1977-08-12
FI64578C (fi) 1983-12-12
JPS5198249A (enrdf_load_stackoverflow) 1976-08-30
IE43821B1 (en) 1981-06-03
FI760002A7 (enrdf_load_stackoverflow) 1976-07-25
GB1538871A (en) 1979-01-24
GR58537B (en) 1977-10-31
CS187333B2 (en) 1979-01-31
NO760214L (enrdf_load_stackoverflow) 1976-07-27
ATA36776A (de) 1978-12-15
NL185203C (nl) 1990-02-16
FI64578B (fi) 1983-08-31
SE7600729L (sv) 1976-07-25
PH14040A (en) 1980-12-12
NO147714C (no) 1983-06-01
SU607550A3 (ru) 1978-05-15
YU40805B (en) 1986-06-30
ZA7681B (en) 1976-12-29
HU174185B (hu) 1979-11-28
DD122517A5 (enrdf_load_stackoverflow) 1976-10-12
AR212328A1 (es) 1978-06-30
CA1076569A (en) 1980-04-29
NO147714B (no) 1983-02-21
BE837865A (fr) 1976-07-23
DK27376A (da) 1976-07-25
FR2298322B1 (enrdf_load_stackoverflow) 1979-09-21
IE43821L (en) 1976-07-24
IL48870A0 (en) 1976-03-31
NL185203B (nl) 1989-09-18
SE446726B (sv) 1986-10-06
CH609682A5 (en) 1979-03-15
DE2601646C2 (enrdf_load_stackoverflow) 1987-07-02
IL48870A (en) 1979-11-30
FR2298322A1 (fr) 1976-08-20
AT351186B (de) 1979-07-10

Similar Documents

Publication Publication Date Title
DE2652256C2 (de) Polyprenylalkohole und diese enthaltende pharmazeutische Zusammensetzungen
DE2437388A1 (de) Prostansaeurederivate
DE2322673A1 (de) Neue verbindungen vom prostaglandintyp und verfahren zu ihrer herstellung
DE2223365C3 (de) Prostansäurederivate, Verfahren zu ihrer Herstellung, solche Derivate enthaltende pharmazeutische und veterinäre Zusammensetzungen sowie Zwischenprodukte zur Herstellung dieser Derivate
CH618968A5 (enrdf_load_stackoverflow)
DE2322142C2 (de) Prostansäurederivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische oder veterinäre Zuammensetzungen
AT367747B (de) Verfahren zur herstellung von optisch aktiven oder racemischen prostaglandinen und ihren salzen
DE2601646A1 (de) Neue prostaglandin-analoga
DE2539116C2 (de) ω-Nor-cycloalkyl-13,14-dehydro-prostaglandine, Verfahren zu ihrer Herstellung sowie sie enthaltende pharmazeutische Mittel
DE2517773A1 (de) Neue 11-oxo-prostaglandin-derivate und verfahren zu ihrer herstellung
DE2610503C2 (de) Optisch aktive 13,14-Dehydro-11- desoxy-prostaglandine, Verfahren zu ihrer Herstellung und sie enthaltendes pharmazeutisches Mittel
DE2360893A1 (de) Cyclopentanderivate
EP0087585A1 (de) Verfahren zur Herstellung von 3-Alkoxi-acrylnitrilen
DE2611788A1 (de) Fluorprostaglandine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
DE2253089C2 (de) 9-Oxo-9,10,seco-östran-Derivate und Verfahren zur Herstellung dieser Verbindungen und von 9-Oxo-D-homo-9,10-seco-östran-Derivaten
DE2355042A1 (de) Neue prostaglandinanaloge und verfahren zu deren herstellung
DE68909143T2 (de) Prostaglandin-Vorläufer und ihre Herstellung.
DE2323454A1 (de) Verfahren zur herstellung von cyclopentenverbindungen
CH638480A5 (de) Prostaglandinverbindungen.
DE2716075A1 (de) Neue zwischenprodukte und verfahren zur herstellung von thromboxan-analoga
DE2637384A1 (de) Prostanderivate
DE2534990A1 (de) Prostansaeurederivate
DE2217044C2 (de) Optisch aktive Prostaglandinderivate und deren racemische Gemische sowie Verfahren zu ihrer Herstellung
DE2406287A1 (de) Verfahren zur herstellung von prostaglandin-analoga
DE2344838C3 (de) 18-Oxa- und 19-Oxa-prostaglandinverbindungen sowie 20-Oxa- und 19-Oxa-omega-homo-prostaglandinverbindungen und Verfahren zu deren Herstellung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition